MEGF9 Antikörper (AA 360-440)

Produktnummer ABIN7214686

Dieser Anti-MEGF9 Antikörper ist ein Kaninchen Polyklonal Antikörper zur Detektion von MEGF9 in WB und ELISA. Geeignet für Human, Maus und Ratte.

Kurzübersicht für MEGF9 Antikörper (AA 360-440) (ABIN7214686)

Target: MEGF9 (Multiple EGF-Like-Domains 9 (MEGF9))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MEGF9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-MEGF9 Antikörper

Bindungsspezifität: AA 360-440

Verwendungszweck: EGFL5 Polyclonal Antibody

Spezifität: EGFL5 Polyclonal Antibody detects endogenous levels of EGFL5 protein.

Aufreinigung: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

Immunogen: Synthesized peptide derived from the Internal region of human EGFL5 at AA range: 360-440

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:40000). Not yet tested in other applications.

Kommentare:

Primary Antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Details zu MEGF9

Target: MEGF9 (Multiple EGF-Like-Domains 9 (MEGF9))

Andere Bezeichnung: EGFL5

Hintergrund: Rabbit Anti-EGFL5 Polyclonal Antibody,MEGF9, EGFL5, KIAA0818, Multiple epidermal growth factor-like domains protein 9, Multiple EGF-like domains protein 9, Epidermal growth factor-like protein 5, EGF-like protein 5,MEGF9 (Multiple EGF-like domains protein 9, also EGF-like protein 5) is a 63 kDa (predicted) novel transmembrane glycoprotein that shares some homology to beta -chains of laminin. It is expressed by hepatocytes, cerebellar Purkinje cells, Schwann cells, keratinocytes and intestinal epithelium. MEGF9 is suggested to participate in cell motility, and its absence correlates with tumor cell migration. Mature human MEGF9 is 572 amino acids (aa) in length. It is a single span type I transmembrane protein that contains a 484 aa extracellular region (aa 31-514) plus a 68 aa C-terminal cytoplasmic domain. The extracellular region possesses a lengthy Pro-rich region (aa 55-200), followed by five EGF-like domains (aa 204-451). MEGF9 may run at approximately 160 kDa in SDS-PAGE, suggesting either heavy glycosylation or dimerization. Over aa 36-514, human MEGF9 shares 76 % aa sequence identity with mouse MEGF9.,Multiple epidermal growth factor-like domains protein 9

Molekulargewicht: observerd band 63kDa

Gen-ID: 1955

UniProt: Q9H1U4